Cargando…
MA08.07 Understanding Lung Cancer Patients’ Preferences in Speaking to Their Treatment Team: Insights from a Global Patient Experience Survey
Autores principales: | Fenemore, J., Boerckel, W., Rigney, M., McNamara, A., Gaspar, B., Mayans, J., Hennink, M., Fox, J., Pretorius, L., Daniels, M., Winstone, S., Thakrar, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452036/ http://dx.doi.org/10.1016/j.jtho.2022.07.122 |
Ejemplares similares
-
P2.08-06 Patient Involvement in Decision-Making around Their Treatment and Care: Findings from a Global Patient Experience Survey
por: Fenemore, J., et al.
Publicado: (2022) -
MA05.01 Patients’ Experiences During COVID-19: Insights from The Second Global Lung Cancer Coalition Patient Experience Survey
por: Fenemore, J., et al.
Publicado: (2021) -
Osteoporosis medication profile preference: results from the PREFER‐US study
por: Weiss, Thomas W., et al.
Publicado: (2007) -
The use of positive end expiratory pressure in patients affected by COVID-19: Time to reconsider the relation between morphology and physiology
por: Perchiazzi, Gaetano, et al.
Publicado: (2020) -
Recommendations for developing clinical care protocols during pandemics: From theory and practice
por: Waterman, Ruth S., et al.
Publicado: (2021)